LXGTF — Lexington Biosciences Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- $0.00m
- $0.00m
Annual cashflow statement for Lexington Biosciences Holdings, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.27 | -0.481 | -0.324 | -0.176 | -0.177 |
| Non-Cash Items | 0.928 | 0.026 | 0 | — | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.131 | 0.13 | 0.297 | 0.175 | 0.177 |
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.21 | -0.325 | -0.027 | -0.001 | 0 |
| Financing Cash Flow Items | 0.116 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 0.116 | 0.34 | 0 | — | — |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.095 | 0.015 | -0.027 | -0.001 | 0 |